Global Tourette Syndrome Drug Market Research Report 2017

December 2017 | 102 pages | ID: GB4C9130899EN
QYResearch

Abstracts

In this report, the global Tourette Syndrome Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Tourette Syndrome Drug in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Tourette Syndrome Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Abide Therapeutics Inc
• Catalyst Pharmaceuticals Inc
• Neurocrine Biosciences Inc
• Psyadon Pharmaceuticals Inc
• Reviva Pharmaceuticals Inc
• Synchroneuron Inc
• Teva Pharmaceutical Industries Ltd
• Therapix Biosciences Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• AZD-5213
• CPP-115
• Dutetrabenazine ER
• Ecopipam Hydrochloride
• Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Research Center
• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Tourette Syndrome Drug Market Research Report 2017

1 TOURETTE SYNDROME DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Tourette Syndrome Drug
1.2 Tourette Syndrome Drug Segment by Type (Product Category)
  1.2.1 Global Tourette Syndrome Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Tourette Syndrome Drug Production Market Share by Type (Product Category) in 2016
  1.2.3 AZD-5213
  1.2.4 CPP-115
  1.2.5 Dutetrabenazine ER
  1.2.6 Ecopipam Hydrochloride
  1.2.7 Others
1.3 Global Tourette Syndrome Drug Segment by Application
  1.3.1 Tourette Syndrome Drug Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Research Center
  1.3.3 Hospital
  1.3.4 Clinic
  1.3.5 Others
1.4 Global Tourette Syndrome Drug Market by Region (2012-2022)
  1.4.1 Global Tourette Syndrome Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Tourette Syndrome Drug (2012-2022)
  1.5.1 Global Tourette Syndrome Drug Revenue Status and Outlook (2012-2022)
  1.5.2 Global Tourette Syndrome Drug Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL TOURETTE SYNDROME DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Tourette Syndrome Drug Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Tourette Syndrome Drug Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Tourette Syndrome Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Tourette Syndrome Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Tourette Syndrome Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Tourette Syndrome Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Tourette Syndrome Drug Market Competitive Situation and Trends
  2.5.1 Tourette Syndrome Drug Market Concentration Rate
  2.5.2 Tourette Syndrome Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL TOURETTE SYNDROME DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Tourette Syndrome Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Tourette Syndrome Drug Production and Market Share by Region (2012-2017)
3.3 Global Tourette Syndrome Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL TOURETTE SYNDROME DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Tourette Syndrome Drug Consumption by Region (2012-2017)
4.2 North America Tourette Syndrome Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Tourette Syndrome Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Tourette Syndrome Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Tourette Syndrome Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Tourette Syndrome Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Tourette Syndrome Drug Production, Consumption, Export, Import (2012-2017)

5 GLOBAL TOURETTE SYNDROME DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Tourette Syndrome Drug Production and Market Share by Type (2012-2017)
5.2 Global Tourette Syndrome Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Tourette Syndrome Drug Price by Type (2012-2017)
5.4 Global Tourette Syndrome Drug Production Growth by Type (2012-2017)

6 GLOBAL TOURETTE SYNDROME DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Tourette Syndrome Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Tourette Syndrome Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL TOURETTE SYNDROME DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Abide Therapeutics Inc
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Catalyst Pharmaceuticals Inc
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Neurocrine Biosciences Inc
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Psyadon Pharmaceuticals Inc
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Reviva Pharmaceuticals Inc
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Synchroneuron Inc
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Synchroneuron Inc Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Teva Pharmaceutical Industries Ltd
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Therapix Biosciences Ltd
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview

8 TOURETTE SYNDROME DRUG MANUFACTURING COST ANALYSIS

8.1 Tourette Syndrome Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Tourette Syndrome Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Tourette Syndrome Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Tourette Syndrome Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL TOURETTE SYNDROME DRUG MARKET FORECAST (2017-2022)

12.1 Global Tourette Syndrome Drug Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Tourette Syndrome Drug Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Tourette Syndrome Drug Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Tourette Syndrome Drug Price and Trend Forecast (2017-2022)
12.2 Global Tourette Syndrome Drug Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Tourette Syndrome Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Tourette Syndrome Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Tourette Syndrome Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Tourette Syndrome Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Tourette Syndrome Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Tourette Syndrome Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Tourette Syndrome Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Tourette Syndrome Drug Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Tourette Syndrome Drug
Figure Global Tourette Syndrome Drug Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Tourette Syndrome Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of AZD-5213
Table Major Manufacturers of AZD-5213
Figure Product Picture of CPP-115
Table Major Manufacturers of CPP-115
Figure Product Picture of Dutetrabenazine ER
Table Major Manufacturers of Dutetrabenazine ER
Figure Product Picture of Ecopipam Hydrochloride
Table Major Manufacturers of Ecopipam Hydrochloride
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Tourette Syndrome Drug Consumption (K Pcs) by Applications (2012-2022)
Figure Global Tourette Syndrome Drug Consumption Market Share by Applications in 2016
Figure Research Center Examples
Table Key Downstream Customer in Research Center
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Tourette Syndrome Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Tourette Syndrome Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Tourette Syndrome Drug Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Tourette Syndrome Drug Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Tourette Syndrome Drug Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Tourette Syndrome Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Tourette Syndrome Drug Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Tourette Syndrome Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Tourette Syndrome Drug Major Players Product Production (K Pcs) (2012-2017)
Table Global Tourette Syndrome Drug Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Tourette Syndrome Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Tourette Syndrome Drug Production Share by Manufacturers
Figure 2017 Tourette Syndrome Drug Production Share by Manufacturers
Figure Global Tourette Syndrome Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Tourette Syndrome Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Tourette Syndrome Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Tourette Syndrome Drug Revenue Share by Manufacturers
Table 2017 Global Tourette Syndrome Drug Revenue Share by Manufacturers
Table Global Market Tourette Syndrome Drug Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Tourette Syndrome Drug Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Tourette Syndrome Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Tourette Syndrome Drug Product Category
Figure Tourette Syndrome Drug Market Share of Top 3 Manufacturers
Figure Tourette Syndrome Drug Market Share of Top 5 Manufacturers
Table Global Tourette Syndrome Drug Capacity (K Pcs) by Region (2012-2017)
Figure Global Tourette Syndrome Drug Capacity Market Share by Region (2012-2017)
Figure Global Tourette Syndrome Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Tourette Syndrome Drug Capacity Market Share by Region
Table Global Tourette Syndrome Drug Production by Region (2012-2017)
Figure Global Tourette Syndrome Drug Production (K Pcs) by Region (2012-2017)
Figure Global Tourette Syndrome Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Tourette Syndrome Drug Production Market Share by Region
Table Global Tourette Syndrome Drug Revenue (Million USD) by Region (2012-2017)
Table Global Tourette Syndrome Drug Revenue Market Share by Region (2012-2017)
Figure Global Tourette Syndrome Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Tourette Syndrome Drug Revenue Market Share by Region
Figure Global Tourette Syndrome Drug Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Tourette Syndrome Drug Consumption (K Pcs) Market by Region (2012-2017)
Table Global Tourette Syndrome Drug Consumption Market Share by Region (2012-2017)
Figure Global Tourette Syndrome Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Tourette Syndrome Drug Consumption (K Pcs) Market Share by Region
Table North America Tourette Syndrome Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Tourette Syndrome Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Tourette Syndrome Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Tourette Syndrome Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Tourette Syndrome Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Tourette Syndrome Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Tourette Syndrome Drug Production (K Pcs) by Type (2012-2017)
Table Global Tourette Syndrome Drug Production Share by Type (2012-2017)
Figure Production Market Share of Tourette Syndrome Drug by Type (2012-2017)
Figure 2016 Production Market Share of Tourette Syndrome Drug by Type
Table Global Tourette Syndrome Drug Revenue (Million USD) by Type (2012-2017)
Table Global Tourette Syndrome Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Tourette Syndrome Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Tourette Syndrome Drug by Type
Table Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2012-2017)
Figure Global Tourette Syndrome Drug Production Growth by Type (2012-2017)
Table Global Tourette Syndrome Drug Consumption (K Pcs) by Application (2012-2017)
Table Global Tourette Syndrome Drug Consumption Market Share by Application (2012-2017)
Figure Global Tourette Syndrome Drug Consumption Market Share by Applications (2012-2017)
Figure Global Tourette Syndrome Drug Consumption Market Share by Application in 2016
Table Global Tourette Syndrome Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Tourette Syndrome Drug Consumption Growth Rate by Application (2012-2017)
Table Abide Therapeutics Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abide Therapeutics Inc Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abide Therapeutics Inc Tourette Syndrome Drug Production Growth Rate (2012-2017)
Figure Abide Therapeutics Inc Tourette Syndrome Drug Production Market Share (2012-2017)
Figure Abide Therapeutics Inc Tourette Syndrome Drug Revenue Market Share (2012-2017)
Table Catalyst Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production Growth Rate (2012-2017)
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production Market Share (2012-2017)
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (2012-2017)
Table Neurocrine Biosciences Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Production Growth Rate (2012-2017)
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Production Market Share (2012-2017)
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Revenue Market Share (2012-2017)
Table Psyadon Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production Growth Rate (2012-2017)
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production Market Share (2012-2017)
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (2012-2017)
Table Reviva Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production Growth Rate (2012-2017)
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production Market Share (2012-2017)
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (2012-2017)
Table Synchroneuron Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Synchroneuron Inc Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Synchroneuron Inc Tourette Syndrome Drug Production Growth Rate (2012-2017)
Figure Synchroneuron Inc Tourette Syndrome Drug Production Market Share (2012-2017)
Figure Synchroneuron Inc Tourette Syndrome Drug Revenue Market Share (2012-2017)
Table Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production Market Share (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Revenue Market Share (2012-2017)
Table Therapix Biosciences Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Therapix Biosciences Ltd Tourette Syndrome Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Production Growth Rate (2012-2017)
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Production Market Share (2012-2017)
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Tourette Syndrome Drug
Figure Manufacturing Process Analysis of Tourette Syndrome Drug
Figure Tourette Syndrome Drug Industrial Chain Analysis
Table Raw Materials Sources of Tourette Syndrome Drug Major Manufacturers in 2016
Table Major Buyers of Tourette Syndrome Drug
Table Distributors/Traders List
Figure Global Tourette Syndrome Drug Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Tourette Syndrome Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Tourette Syndrome Drug Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Tourette Syndrome Drug Production Market Share Forecast by Region (2017-2022)
Table Global Tourette Syndrome Drug Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Tourette Syndrome Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Tourette Syndrome Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Tourette Syndrome Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Tourette Syndrome Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Tourette Syndrome Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Tourette Syndrome Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Tourette Syndrome Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Tourette Syndrome Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Tourette Syndrome Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Tourette Syndrome Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Tourette Syndrome Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Tourette Syndrome Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Tourette Syndrome Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Tourette Syndrome Drug Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Tourette Syndrome Drug Production (K Pcs) Forecast by Type (2017-2022)
Table Global Tourette Syndrome Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Tourette Syndrome Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Tourette Syndrome Drug Price Forecast by Type (2017-2022)
Table Global Tourette Syndrome Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Tourette Syndrome Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source